SEC CIK 2056547
Paladin Michael Shane
Reported ownership across 2 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| EQIXview stock → | 2,450.485 | 2026-09-04 |
| SMRTview stock → | 0 | 2025-05-12 |
Position History — EQIX
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — EQIX
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-09-04 | Open-market sale | 307 | $1035.01 | 2,450.485 |
| 2026-09-02 | Open-market sale | 150 | $1018.43 | 2,757.485 |
| 2026-09-02 | Open-market sale | 53 | $1008.02 | 2,907.485 |
| 2026-09-01 | Option exercise (derivative) | 510 | $0.00 | 510 |
| 2026-09-01 | Option exercise | 510 | $0.00 | 2,960.485 |
| 2026-03-12 | Open-market sale | 6 | $969.89 | 2,450.485 |
| 2026-03-12 | Open-market sale | 52 | $969.12 | 2,456.485 |
| 2026-03-12 | Open-market sale | 24 | $968.01 | 2,508.485 |
| 2026-03-12 | Open-market sale | 8 | $964.05 | 2,532.485 |
| 2026-03-12 | Open-market sale | 12 | $962.55 | 2,540.485 |
| 2026-03-12 | Open-market sale | 12 | $960.50 | 2,552.485 |
| 2026-03-12 | Open-market sale | 4 | $958.14 | 2,564.485 |
| 2026-03-11 | Option exercise (derivative) | 297 | $0.00 | 0 |
| 2026-03-11 | Grant / award (derivative) | 297 | $0.00 | 297 |
| 2026-03-11 | Option exercise | 297 | $0.00 | 2,568.485 |
| 2026-03-03 | Open-market sale | 7 | $946.83 | 2,472.49 |
| 2026-03-03 | Open-market sale | 7 | $948.03 | 2,465.49 |
| 2026-03-03 | Open-market sale | 21 | $950.29 | 2,444.49 |
| 2026-03-03 | Open-market sale | 17 | $952.91 | 2,427.49 |
| 2026-03-03 | Open-market sale | 14 | $953.77 | 2,413.49 |
| 2026-03-03 | Open-market sale | 22 | $955.70 | 2,391.49 |
| 2026-03-03 | Open-market sale | 61 | $956.55 | 2,330.49 |
| 2026-03-03 | Open-market sale | 52 | $957.72 | 2,278.49 |
| 2026-03-03 | Open-market sale | 7 | $959.44 | 2,271.49 |
| 2026-03-02 | Option exercise (derivative) | 510 | $0.00 | 1,020 |
| 2026-03-02 | Option exercise | 510 | $0.00 | 2,479.49 |
| 2026-02-18 | Open-market sale | 80 | $927.07 | 2,562.49 |
| 2026-02-18 | Open-market sale | 80 | $934.27 | 2,209.49 |
| 2026-02-18 | Open-market sale | 40 | $932.08 | 2,289.49 |
| 2026-02-18 | Open-market sale | 60 | $930.37 | 2,329.49 |
| 2026-02-18 | Open-market sale | 173 | $928.01 | 2,389.49 |
| 2026-02-18 | Open-market sale | 40 | $938.94 | 2,169.49 |
| 2026-02-18 | Open-market sale | 40 | $940.10 | 2,129.49 |
| 2026-02-18 | Open-market sale | 40 | $941.58 | 2,089.49 |
| 2026-02-18 | Open-market sale | 80 | $942.77 | 2,009.49 |
| 2026-02-18 | Open-market sale | 40 | $948.30 | 1,969.49 |
| 2026-02-17 | Option exercise (derivative) | 1,626 | $0.00 | 1,626 |
| 2026-02-17 | Grant / award (derivative) | 3,252 | $0.00 | 3,252 |
| 2026-02-17 | Option exercise | 1,626 | $0.00 | 2,642.49 |
| 2026-02-06 | Grant / award (derivative) | 3,743 | $0.00 | 3,743 |
| 2026-01-16 | Open-market sale | 24 | $801.54 | 1,231 |
| 2026-01-16 | Open-market sale | 79 | $806.67 | 952 |
| 2026-01-16 | Open-market sale | 88 | $805.62 | 1,031 |
| 2026-01-16 | Open-market sale | 12 | $800.23 | 1,255 |
| 2026-01-16 | Open-market sale | 12 | $798.04 | 1,267 |
| 2026-01-16 | Open-market sale | 52 | $802.34 | 1,179 |
| 2026-01-16 | Open-market sale | 60 | $804.44 | 1,119 |
| 2026-01-15 | Option exercise (derivative) | 777 | $0.00 | 1,553 |
| 2026-01-15 | Option exercise | 777 | $0.00 | 1,279 |
| 2025-10-07 | Option exercise (derivative) | 824 | $0.00 | 1,530 |
| 2025-10-07 | Tax withholding | 322 | $787.08 | 502 |
| 2025-10-07 | Option exercise | 824 | $0.00 | 824 |
| 2025-07-12 | Grant / award (derivative) | 2,330 | $0.00 | 2,330 |
| 2025-07-12 | Grant / award (derivative) | 2,354 | $0.00 | 2,354 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.